Tagenarayan Niwaz in New York, New York

Home New York New York

Tagenarayan Niwaz has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 111 Broadway in New York, New York. There are 4 additional office locations for Tagenarayan Niwaz that can be viewed towards the end of their profile.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-9700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended New York College Of Osteo Medicine Of New York Institute Of Technology and graduated in 2011 (around 13 years of experience). They are listed as doing telehealth appointments.

Tagenarayan Niwaz Office Phone and Directions

Tagenarayan Niwaz
New York University
111 Broadway
New York, New York 10006
212-263-9700

Patient Ratings
Please rate your experience with Tagenarayan Niwaz below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-263-9700

Enter a starting address:

Healthcare Info for Tagenarayan Niwaz

Medical School: New York College Of Osteo Medicine Of New York Institute Of Technology
Graduation Year: 2011
The Primary Medical Specialty for Tagenarayan Niwaz is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 13
PAC (PECOS ID)#: 5395012736
NPI #: 1497046833
NPI Created On: 04/19/2011
NPI Last Updated Listed as: 03/08/2021
Primary Taxonomy Code: 207RC0000X
License Number:
287163
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Routine ekg using at least 12 leads including interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Technetium tc-99m sestamibi, diagnostic, per study dose
Injection, regadenoson, 0.1 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $74

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788312303

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788312305

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788312307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788312309

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788312311

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788312313

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788312315

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813122715

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813122719

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833391585

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: GASTROINTESTINAL

Name Of Drug #2:: COLOGUARD DNA CAPTURE REAGENTS

Additional Office Locations

1. New York University
530 1st Ave
New York, NY 10016
Group Members: 4,291

Phone: 212-263-9700

Enter a starting address:

2. New York University
550 1st Ave
New York, NY 10016
Group Members: 4,291

Phone: 212-263-9700

Enter a starting address:

3. New York University
560 1st Ave
New York, NY 10016
Group Members: 4,291

Phone: 212-263-9700

Enter a starting address:

4. New York University
180 E Pulaski Rd
Huntington Station, NY 11746
Group Members: 4,291

Enter a starting address:

Cardiovascular Disease (cardiology) Professionals in New York

1.
John Dodson

16 Th St And 1st Ave
New-york, NY
New York University

2.
John Dodson

301 E 17th St
New-york, NY
New York University

3.
John Dodson

111 Broadway
New-york, NY
New York University

4.
John Dodson

240 E 38th St
New-york, NY
New York University

5.
John Dodson

530 1st Ave
New-york, NY
New York University

6.
John Dodson

550 1st Ave
New-york, NY
New York University

Providers in New York University

1.Jennifer Abate

240 E 38th St
New York Ny 10016-2708
New York University
Nurse Practitioner

2.Nabil Abazaid

111 Broadway
New York Ny 10006-1901
New York University
Emergency Medicine

3.Valentino Abballe

16 Th St And 1st Ave
New York Ny 10003-3804
New York University
Diagnostic Radiology

4.Valentino Abballe

301 E 17th St
New York Ny 10003-3804
New York University
Diagnostic Radiology

5.Valentino Abballe

111 Broadway
New York Ny 10006-1901
New York University
Diagnostic Radiology

6.Valentino Abballe

111 Broadway
New York Ny 10006-1995
New York University
Diagnostic Radiology

View all 4,291 members of New York University medical group